RxDoctor Payments Data

Linda Staley

Adult Health · Phoenix, AZNPI 1043293889

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 160 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Abbott at 47.1% of the total. Reporting peaked in 2024 at $2,111 and has fallen 52.4% since, to $1,004 in 2025. Among adult health clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,890in general payments, 2019–2025

Across 160 payments — averaging $36.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$567
  • Abiomed$458
  • AstraZeneca$277
  • Boehringer Ingelheim$272
  • Novartis$265
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$5,890100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,890 in reported general payments places this provider in the 90th percentile of 314 adult health providers in Arizona.

See all adult health providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan21$22,412
JardianceEmpagliflozin32$21,616
Bumetanide31$1,441
Amiodarone Hcl23$459
Digoxin22$396
Atorvastatin Calcium37$346
Potassium Chloride12$239
Metoprolol Succinate15$208
Gabapentin15$203
Pantoprazole Sodium21$193
Losartan Potassium31$186
Tamsulosin Hcl19$184
Warfarin Sodium18$171
Spironolactone30$140

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$265$22,41221 claims
Boehringer IngelheimJardiance$272$21,61632 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 314 adult health providers in Arizona.

Other adult health in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →